Rubius Therapeutics' Series B Round

Rubius Therapeutics raised a round of funding on June 21, 2017. Investors include Flagship Pioneering.

Rubius Therapeutics is developing Red-Cell Therapeutics (RCTs) as a new treatment modality to address a wide array of indications including cancer, autoimmune disease, rare disease and metabolic disea…

Articles about Rubius Therapeutics' Series B Round: